Paper · 23737352

Recurrence of high-risk bladder cancer: a population-based analysis.

Chamie K and 8 others. Cancer, 2013. Cited by 274 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Recurrence of high-risk bladder cancer: a population-based analysis. Papers, record 23737352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23737352

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Recurrence of high-risk bladder cancer: a population-based analysis.; PubMed
Journal: Cancer; PubMed
Year: 2013; PubMed
Publication types: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/23737352/; PubMed
DOI: https://doi.org/10.1002/cncr.28147; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC3773281/; PubMed
The journal: https://conductscience.org/library/journal-index/0374236; PubMed
Citations, by iCite: 274; iCite
Relative citation ratio, by iCite: 8.06; iCite
Revised in PubMed: 2022-03-30; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind
1	Chamie K	Karim
2	Litwin MS	Mark S
3	Bassett JC	Jeffrey C
4	Daskivich TJ	Timothy J
5	Lai J	Julie
6	Hanley JM	Jan M
7	Konety BR	Badrinath R
8	Saigal CS	Christopher S
9	Urologic Diseases in America Project		Group

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Neoplasm Recurrence, Local	Major topic
Urinary Bladder Neoplasms	Major topic
Aged
Aged, 80 and over
Disease Progression
Female
Humans
Incidence
Male
Morbidity
Multivariate Analysis
Neoplasm Grading
Neoplasm Staging
Odds Ratio
Risk Factors
SEER Program
Sex Factors
Survival Rate
Time Factors
United States

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
F32 CA144461	NCI NIH HHS	United States	F32CA144461	PubMed and NIH	NIH RePORTER
L30 CA154326	NCI NIH HHS	United States	L30CA154326	PubMed and NIH	NIH RePORTER
1 F32 CA144461-01	NCI NIH HHS	United States	F32CA144461	PubMed and NIH	NIH RePORTER
N01-DK-1-2460	NIDDK NIH HHS	United States		PubMed	PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Comment in	24,745,483	Re: recurrence of high-risk bladder cancer: a population-based analysis.	https://conductscience.org/library/papers/24745483

Source PubMed

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	17,552,951	The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.	BJU Int	2007	https://conductscience.org/library/papers/17552951	PubMed
2	21,823,107	Quality of care in patients with bladder cancer: a case report?	Cancer	2012	https://conductscience.org/library/papers/21823107	PubMed
3	17,222,605	Defining optimal therapy for muscle invasive bladder cancer.	J Urol	2007	https://conductscience.org/library/papers/17222605	PubMed
4	16,600,718	The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy.	J Urol	2006	https://conductscience.org/library/papers/16600718	PubMed
5	12,187,163	Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.	Med Care	2002	https://conductscience.org/library/papers/12187163	PubMed
6	9,072,570	The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study.	J Urol	1997	https://conductscience.org/library/papers/9072570	PubMed
7	19,152,434	Understanding bladder cancer death: tumor biology versus physician practice.	Cancer	2009	https://conductscience.org/library/papers/19152434	PubMed
8	3,558,716	A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.	J Chronic Dis	1987	https://conductscience.org/library/papers/3558716	PubMed
9	16,442,208	Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.	Eur Urol	2006	https://conductscience.org/library/papers/16442208	PubMed
10	19,171,491	Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer.	Urol Oncol	2010	https://conductscience.org/library/papers/19171491	PubMed

1 to 10 of 31

See all 31 references

Cited by199

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 274 citations.

PMID	Title	Journal	Year	In Papers	Source
42,960,345	Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data.	Curr Urol	2026	https://conductscience.org/library/papers/42960345	PubMed
42,908,026	Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.	Cancer Cell Int	2026	https://conductscience.org/library/papers/42908026	PubMed
42,778,943	Functional characterization of FAM120A as a novel effector in the progranulin/EphA2 oncogenic axis in bladder cancer.	J Exp Clin Cancer Res	2026	https://conductscience.org/library/papers/42778943	PubMed
42,694,519	Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review.	Ther Adv Urol	2026	https://conductscience.org/library/papers/42694519	PubMed
42,485,786	Centrosome-related gene SPHK1 drives bladder cancer progression and therapeutic vulnerability.	Transl Oncol	2026	https://conductscience.org/library/papers/42485786	PubMed
42,401,771	LC-MS-Based Metabolomics and Proteomics Sample Preparation of Urine: Methods and Multi-Omics Integration.	Adv Exp Med Biol	2026	https://conductscience.org/library/papers/42401771	PubMed
42,239,304	Immunodominance Hierarchy of Endogenous BBN963 Bladder Cancer Antigens Remains Stable Under Anti-PD1 and Anti-CTLA4 Immunotherapy.	bioRxiv	2026	https://conductscience.org/library/papers/42239304	PubMed
42,231,026	An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing.	Br J Cancer	2026	https://conductscience.org/library/papers/42231026	PubMed
42,133,100	The synergistic applications of organoids and exosomes in disease modeling and disease treatment.	Mol Biol Rep	2026	https://conductscience.org/library/papers/42133100	PubMed
42,127,904	Nectin4-targeted molecular imaging for precise endoscopic diagnosis and image-guided surgery in bladder cancer.	Cell Rep Med	2026	https://conductscience.org/library/papers/42127904	PubMed

1 to 10 of 199

See all 199 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23737352

GET https://conductscience.org/api/papers/v1/23737352/references?page=2

API reference For AI assistants